Çekiç, ŞükrüKarali, YasinCanıtez, YakupSapan, Nihat2024-07-252024-07-252018-08-010105-4538https://hdl.handle.net/11452/43448Bu çalışma, 26-30, Mayıs 2018 tarihlerinde Munich[Almanya]’da düzenlenen Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineAllergyImmunologyOmalizumab treatment in childhood chronic urticariaMeeting Abstract000441690401184227227731398-9995